Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Socie

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2022
Long-Term Outcomes After Transplantation for Acute Myelogenous LeukemiaGerard Socie
Blood|June 9, 2025
Challenges in GVHD and GVL after hematopoietic stem cell transplantation for myeloid malignanciesGerard Socie
Frontiers in Immunology|December 22, 2022
Milestones in acute GVHD pathophysiologyGerard Socie, David Michonneau
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2009
Current challenges in chronic graft-versus-host diseaseGerard Socie, Jerome Ritz, Paul J Martin
Blood|April 4, 2002
Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host diseaseMarjan Daneshpouy, Gerard Socie, Marc Lemann, et al.
Blood|November 16, 2006
Donor-derived cells and human graft-versus-host disease of the skinHideyuki Murata, Anne Janin, Christophe Leboeuf, et al.
Blood|November 18, 2006
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)Gerard Socie, Jean-Yves Mary, Hubert Schrezenmeier, et al.
British Journal of Haematology|June 11, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host diseaseMichael Pratta, Sophie Paczesny, Gerard Socie, et al.
The Lancet. Haematology|June 7, 2017
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialJürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, et al.
Haematologica|August 28, 2025
Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantationJonathan Bordat, Eleonore Kaphan, Marie Robin, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2022
Long-Term Outcomes After Transplantation for Acute Myelogenous LeukemiaGerard Socie
Blood|June 9, 2025
Challenges in GVHD and GVL after hematopoietic stem cell transplantation for myeloid malignanciesGerard Socie
Frontiers in Immunology|December 22, 2022
Milestones in acute GVHD pathophysiologyGerard Socie, David Michonneau
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2009
Current challenges in chronic graft-versus-host diseaseGerard Socie, Jerome Ritz, Paul J Martin
Blood|April 4, 2002
Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host diseaseMarjan Daneshpouy, Gerard Socie, Marc Lemann, et al.
Blood|November 16, 2006
Donor-derived cells and human graft-versus-host disease of the skinHideyuki Murata, Anne Janin, Christophe Leboeuf, et al.
Blood|November 18, 2006
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)Gerard Socie, Jean-Yves Mary, Hubert Schrezenmeier, et al.
British Journal of Haematology|June 11, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host diseaseMichael Pratta, Sophie Paczesny, Gerard Socie, et al.
The Lancet. Haematology|June 7, 2017
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialJürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, et al.
Haematologica|August 28, 2025
Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantationJonathan Bordat, Eleonore Kaphan, Marie Robin, et al.
Pageof 8